Actively Recruiting
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
Led by Addpharma Inc. · Updated on 2025-03-20
60
Participants Needed
1
Research Sites
3 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228B in healthy subjects.
CONDITIONS
Official Title
A Study to Compare PK Characteristics and Safety Profiles Between AD-228B and AD-2284
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
- Age equal to or greater than 19 in healthy volunteers at the time of screening visit
You will not qualify if you...
- Participation in other clinical study with an investigational drug within the 6 months from scheduled first administration
- Other exclusions applied
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
H Plus Yangji Hospital
Seoul, South Korea
Actively Recruiting
Research Team
J
JeongEun Park
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here